Looking to prepare for the next flu pandemic, Sanofi drops $700M+ into new Toronto facility for Fluzone production
With Covid-19 variants potentially sticking around in the human population for years to come and clogging up hospitals, public health officials are spotlighting the need …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.